Heart Test Laboratories (NASDAQ:HSCS – Get Free Report)‘s stock had its “buy” rating restated by Ascendiant Capital Markets in a research note issued on Monday, Benzinga reports. They presently have a $15.00 price target on the stock. Ascendiant Capital Markets’ price target would indicate a potential upside of 391.80% from the stock’s current price.
Heart Test Laboratories Stock Up 2.0 %
Shares of NASDAQ:HSCS traded up $0.06 during midday trading on Monday, reaching $3.05. The company’s stock had a trading volume of 6,467 shares, compared to its average volume of 56,989. The stock has a fifty day moving average of $3.40 and a 200 day moving average of $6.57. Heart Test Laboratories has a twelve month low of $2.36 and a twelve month high of $52.00. The firm has a market capitalization of $2.00 million, a PE ratio of -0.06 and a beta of 3.13.
Heart Test Laboratories Company Profile
Featured Articles
- Five stocks we like better than Heart Test Laboratories
- Retail Stocks Investing, Explained
- The Average 401k Balance by Age Explained
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- ESG Stocks, What Investors Should Know
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.